This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74117541
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2002 im Mai 2002 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en mayu de 2002 wetenschappelijk artikel scientific article published on 01 May 2002 наукова стаття, опублікована в травні 2002
p:P577
wds:Q74117541-3A0BE017-5ADF-4076-9BF3-6BB37C63CE72
wdt:P577
2002-05-01T00:00:00Z
p:P407
wds:Q74117541-A7B6FDED-8CF0-4D85-99BA-42F61A634107
wdt:P407
wd:Q1860
p:P2860
wds:Q74117541-FA8D7EA6-6238-42AA-A056-CDCDCD8B9632 wds:Q74117541-F6662EC7-C50F-44BA-AA58-1CB6EF6DABB6 wds:Q74117541-F79DEB04-4F65-4A8F-851C-0D6BDED7BEE2 wds:Q74117541-F7A12B64-E01E-49C7-96F1-507B665C855C wds:Q74117541-BCFF0C8F-F560-4686-B4AE-F4AB3A2FBDB7 wds:Q74117541-CDDC369B-9C4A-4516-979B-0E51B24F63AC wds:Q74117541-E63669F7-E6AF-4A42-9369-D3D9AA8D0E72 wds:Q74117541-EA6A2249-C257-4A43-B255-87B170999367 wds:Q74117541-AEA1FCD2-C030-4945-8C8D-9EF25118B03B wds:Q74117541-B5411CF8-5F7D-4100-884C-2F9BEA4B3AF6 wds:Q74117541-B6B43D7E-90B2-4C12-B771-ABE30E442BBE wds:Q74117541-B8B296F0-FF87-4EC5-B03D-42B0CB54F213 wds:Q74117541-9B8A761D-74F4-4CA0-9F62-98B71BF5B017 wds:Q74117541-9EC71FC7-9B8C-4E03-8916-8EBAC2792006 wds:Q74117541-A1C8B938-5B23-44CF-99BF-4882B2604AB6 wds:Q74117541-9015163E-59E1-4BF0-A611-A9598826EF9D wds:Q74117541-94C10A96-ABEF-4208-8FF8-4B7E6D0445F9 wds:Q74117541-854DF565-7B4B-410F-B50D-256C897DEBB2 wds:Q74117541-665F8CBC-7E4B-4A50-A023-1E2F2E5BA736 wds:Q74117541-68230C64-6507-4834-BF35-4E045BD252D2 wds:Q74117541-4FEE5DE1-1B7B-44A3-BB6B-F189F14B3009 wds:Q74117541-55CB4BDB-29E2-4536-B765-9C3870994582 wds:Q74117541-56218252-F8E8-4936-857A-4DE6C7596A45 wds:Q74117541-36234216-DFB3-46BB-A736-98A626DB1393 wds:Q74117541-45225AB4-C3BB-46D3-B248-DFE00428B227 wds:Q74117541-455EC2FA-E915-4DCE-A2DA-2E5C5623D1CE wds:Q74117541-3119F482-A272-4CCF-AFA8-6E185D55AA96 wds:Q74117541-088A299C-E419-4B20-9534-95F124C7E05D wds:Q74117541-0A1B9A0D-2798-4A76-A202-8938AEEE1572 wds:Q74117541-22EB67A9-FFA6-4113-A945-2297E39BBC4C wds:Q74117541-03CE5245-B0D0-4892-84E2-DD892DB47943
wdt:P2860
wd:Q34520432 wd:Q73893207 wd:Q43422059 wd:Q24336806 wd:Q53929522 wd:Q29547667 wd:Q34365252 wd:Q35927191 wd:Q39458533 wd:Q43729271 wd:Q33933240 wd:Q29615031 wd:Q34135695 wd:Q35208288 wd:Q35208402 wd:Q57338722 wd:Q34019131 wd:Q35206764 wd:Q24650807 wd:Q33179635 wd:Q73677622 wd:Q60584728 wd:Q28032484 wd:Q28190064 wd:Q24562644 wd:Q33853609 wd:Q73540284 wd:Q29547356 wd:Q41053539 wd:Q40836730 wd:Q24324559
p:P2093
wds:Q74117541-6638C9F9-56D1-4F04-A967-4889CF6BCA55 wds:Q74117541-9A2FC31B-4A7D-449C-9F22-4FAD0770371A wds:Q74117541-6B224A62-EF6D-45F3-ACF8-7DF41E2249EB wds:Q74117541-8538E316-A7C1-49CA-A446-6B74982E5503 wds:Q74117541-707AEE46-D0E0-4EDE-A7FC-A00343B28CFE wds:Q74117541-FB57D956-FFE5-4C80-9F2E-76390E479940
wdt:P2093
Jordan S Fridman Scott W Lowe Clemens A Schmitt Robert M Hoffman Meng Yang Eugene Baranov
rdfs:label
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
skos:prefLabel
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
schema:name
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
p:P50
wds:Q74117541-23D1219B-DD1E-439C-ADA0-0F728F8D3367
wdt:P50
wd:Q95994020
p:P1476
wds:Q74117541-04D3BA88-F409-4600-ACF3-B5152BA4AC47
wdt:P1476
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
p:P304
wds:Q74117541-9A3B66EE-15A2-434D-89A6-92245E80550D
wdt:P304
335-346
p:P31
wds:Q74117541-2999E24D-5654-4BD9-994D-85C0E364C4FF
wdt:P31
wd:Q13442814
p:P698
wds:Q74117541-2D6E9865-7BA6-44F4-A49D-93C746B39ACE
wdtn:P698
n12:12015983
wdt:P698
12015983
p:P1433
wds:Q74117541-F379A780-F721-49E0-8504-276C9FD482E4
wdt:P1433
wd:Q655814
p:P433
wds:Q74117541-66B07173-799F-4597-897B-6970C1FF519C
p:P478
wds:Q74117541-740C706A-B267-4A7B-B78C-A99F742A930D
wdt:P433
3
wdt:P478
109
p:P356
wds:Q74117541-338378AC-C4F2-4A4B-9813-450487426364
wdtn:P356
n10:S0092-8674(02)00734-1
wdt:P356
10.1016/S0092-8674(02)00734-1